M&A
confidence high
sentiment neutral
materiality 0.95
NeueHealth, Inc.: M&A transaction — NeueHealth taken private by NEA affiliate at $7.33/share; enterprise value ~$1.496B
NeueHealth, Inc.
- Merger closed Oct 2, 2025; common stockholders (excluding rollover/excluded) receive $7.33/share cash.
- Enterprise value ~$1.496B; certain stockholders including NEA roll equity into private company.
- CEO Mike Mikan and executive team remain; 100% equity rolled over; board replaced with new directors.
- Company notified NYSE to delist; intends to file Form 15 to suspend SEC reporting obligations.
- Loan agreement amended: $25M tranche 2A funded; minimum cash covenant raised to $25M; total loan commitments remain $95M.